Patents by Inventor Ramil Latypov

Ramil Latypov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION COMPRISING BISPECIFIC ANTIBODY CONSTRUCTS
    Publication number: 20230103401
    Abstract: The present invention provides novel and stable pharmaceutical compositions comprising bispecific single chain antibody constructs, cyclodextrins and a buffer.
    Type: Application
    Filed: June 30, 2022
    Publication date: April 6, 2023
    Inventors: Sekhar Kanapuram, Ramil Latypov, Balakumar Thangaraj, Cornelius Pompe
  • ANTI-TGF-BETA ANTIBODY FORMULATIONS AND THEIR USE
    Publication number: 20230036928
    Abstract: The present disclosure provides pharmaceutical compositions comprising anti-TGF-? antibodies and methods of use thereof.
    Type: Application
    Filed: June 17, 2022
    Publication date: February 2, 2023
    Applicant: Genzyme Corporation
    Inventors: Kiran Rana BANGARI, Ramil LATYPOV, Timothy MCCOY, Sanket PATKE
  • Pharmaceutical composition comprising bispecific antibody constructs
    Patent number: 11419933
    Abstract: The present invention provides novel and stable pharmaceutical compositions comprising bispecific single chain antibody constructs, cyclodextrins and a buffer.
    Type: Grant
    Filed: January 25, 2017
    Date of Patent: August 23, 2022
    Assignees: AMGEN INC., AMGEN RESEARCH (MUNICH) GMBH
    Inventors: Sekhar Kanapuram, Ramil Latypov, Balakumar Thangaraj, Cornelius Pompe
  • Protein Solubility Screening Kits and Their Use
    Publication number: 20220042977
    Abstract: The present invention provides a multitude of biomacromolecule solubility screening kits, and methods of using such kits. Such kits provide a substantial improvement over presently available kits and methods and provide a substantial decrease in the amounts of biomacromolecules required to run such solubility screening.
    Type: Application
    Filed: August 4, 2020
    Publication date: February 10, 2022
    Applicant: ProStabilis, Inc.
    Inventors: Ramil Latypov, Yongwu Yang
  • PHARMACEUTICAL COMPOSITION COMPRISING BISPECIFIC ANTIBODY CONSTRUCTS
    Publication number: 20170209571
    Abstract: The present invention provides novel and stable pharmaceutical compositions comprising bispecific single chain antibody constructs, cyclodextrins and a buffer.
    Type: Application
    Filed: January 25, 2017
    Publication date: July 27, 2017
    Inventors: Sekhar Kanapuram, Ramil Latypov, Balakumar Thangaraj, Cornelius Pompe
  • Formulated Receptor Polypeptides and Related Methods
    Publication number: 20170202909
    Abstract: Disclosed herein is an activin receptor IIB-based composition and related methods of use, e.g., to treat solid tumors. Also disclosed are methods of manufacturing the compound and formulation.
    Type: Application
    Filed: June 15, 2015
    Publication date: July 20, 2017
    Applicants: Santa Maria Biotherapeutics, Inc., Amgen, Inc.
    Inventors: Christopher Michael Haqq, Ramil Latypov